ArticleAAPS PharmSciTech2025
Multistep Machine Learning Pipeline For Polymeric Nanoparticle Design.
Article in AAPS PharmSciTech, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Application of Machine Learning in the Development of Co-Amorphous Dry Powder Inhalation.AAPS PharmSciTech · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Integrating machine learning (ML) into nanotechnology represents a promising strategy for rational design and accelerated development of drug delivery systems. However, studies in this field are scarce and face methodological and interpretative problems. This study presents a modular ML pipeline for the predictive modeling of nanoparticles produced via nanoprecipitation using isoniazid as a model drug. The workflow was structured into three sequential steps: (1) binary classification to predict nanoparticle formation, (2) multiclass classification to estimate size ranges, and (3) regression to refine size prediction. Several algorithms were used, including Extreme Gradient Boosting, Random Forest, Artificial Neural Networks (ANN), Generalized Linear Models, and Naive Bayes. A total of 90 formulations were evaluated over three iterative experimental rounds. In each cycle, models were retrained with new data and used to simulate virtual formulations, thereby guiding the selection of experiments to reduce data imbalance and improve prediction accuracy. The ANN algorithm consistently outperformed other models in all steps, achieving an R
Indexed as
Identifiers
41168484What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.